Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives
BioSpectrum Asia’s 23 Life Science trends to watch in 2023

BioSpectrum Asia recently published an article titled “23 Life Sciences trends to watch in 2023”, where a range of industry experts provided their predictions.
For 2023, IR Department’s Managing Director, Jane Lowe predicts that:
“I would expect to see life science companies that have been holding off on public market secondary raises come out of the woodwork to shore up their balance sheets. It feels like the market is starting to become more receptive to these raises, while the IPO market remains soft.” (Number 14. The booming of emerging companies).
To read the full article, CLICK HERE
